Ralph  Reisfeld , Ph.D.

Scripps Research Institute
email: reisfeld@scripps.edu
 

Grants

Novel DNA vaccines for the treatment of lung cancer 2003 (Cycle XII)
  12RT-0002 $783,900
Novel DNA vaccines for the treatment of lung cancer 2000 (Cycle IX)
  9RT-0017 $1,063,300

Periodicals

DNA vaccines suppress tumor growth and metastases by the inductiin of anti-angiogenesis,
  Periodical: Immunological Reviews
  Author(s): Reisfeld R.A
  Yr: 2005 Vol: 199 Nbr: Pgs: 181 - 190
  Associated Grant: Novel DNA vaccines for the treatment of lung cancer
     
DNA Vaccine Targeting Survivin Combines Apoptosis with Suppression of Angiogenesis in Lung tumor eradication,
  Periodical: Cancer Research
  Author(s): Xiang, R., Mizutani, N., Luo, Y.,
  Yr: 2005 Vol: 65 Nbr: 2 Pgs: 553 - 561
  Associated Grant: Novel DNA vaccines for the treatment of lung cancer
     
A DNA vaccine encoding murine Tie-2 suppresses effective angiogenesis and induces protection against tumor growth.
  Periodical: American Association for Cancer Research
  Author(s): Reisfeld RA
  Yr: 2004 Vol: Nbr: Pgs:
  Associated Grant: Novel DNA vaccines for the treatment of lung cancer
     
A DNA minigene vaccine against VEGF receptor 2 (FLK-1) suppresses angiogenesis and successfully inhibits growth of prostate and lung carcinoma in mice
  Periodical: American Association for Cancer Research
  Author(s): Reisfeld RA
  Yr: 2004 Vol: Nbr: Pgs:
  Associated Grant: Novel DNA vaccines for the treatment of lung cancer
     
A novel strategy to suppress lung tumor growth with a DNA vaccine targeting survivin.
  Periodical: American Association for Cancer Research
  Author(s): Reisfeld RA
  Yr: 2003 Vol: Nbr: Pgs:
  Associated Grant: Novel DNA vaccines for the treatment of lung cancer
     
A DNA vaccine against vascular endothelial growth factor receptor 2 prevents effective angiogenesis and inhibits tumor growth.
  Periodical: Nature Medicine
  Author(s): Niethammer AG, Xiang R, Becker JC, Wodrich H, Pertl U, Karsten G, Reisfeld RA, et al
  Yr: 2002 Vol: 8 Nbr: Pgs: 1369-1375
  Associated Grant: Novel DNA vaccines for the treatment of lung cancer
     
An oral DNA vaccine against human carcinoembryonic antigen (CDA) prevents growth and dissemination of Lewis lung carcinoma in CEA transgenic mice.
  Periodical: Vaccine
  Author(s): Niethammer AG, Primus FJ, Xiang R, Dolman CS, Ruehlmann JM, Gillies SD, Reisfeld RA
  Yr: 2001 Vol: 20 Nbr: Pgs: 421-429
  Associated Grant: Novel DNA vaccines for the treatment of lung cancer
     
An oral DNA vaccine against human carcinoembryonic antigen (CEA) prevents growth and dissemination of Lewis lung carcinoma in CEA transgenic mice
  Periodical: Vaccine
  Author(s): Niethammer, A.G., Primus, F.J., Xiang, Dolman, Ruehlmann, Gillies, and Reisfeld, R.A.
  Yr: 2001 Vol: 20 Nbr: Pgs: 421-429
  Associated Grant: Novel DNA vaccines for the treatment of lung cancer